Using Organ-On-A-Chip Technology To Unlock Patient-Derived Precision Medicine

Personalized medicine promises treatments tailored to how each patient’s biology responds, but real-world decision-making still leans heavily on limited biomarkers and simplified lab models. These approaches often miss the dynamic complexity of living human tissues, where fluid flow, mechanical forces, and multi-cell interactions shape therapeutic outcomes. Organ-on-a-Chip technology is advancing this gap by recreating key aspects of human physiology in microengineered systems seeded with patient-derived cells. By more accurately reflecting how tissues behave under treatment, these platforms offer a practical path to predicting efficacy, reducing trial-and-error prescribing, and minimizing unnecessary toxicity.

Gain insight into how this approach is reshaping individualized care, with case studies that demonstrate its growing role in translating patient-specific biology into actionable clinical insights.